A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer

Lung Cancer

Volumn 49, Issue 3, 2005, Pages 395-400

  Stephens, Richard J ^a   Girling, David J ^a   Hopwood, Penelope ^b   Thatcher, Nicholas ^b  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Neo adjuvant chemotherapy; Non small cell lung cancer; Radical radiotherapy; Randomised trial

Indexed keywords

ANTIEMETIC AGENT; CISPLATIN; IFOSFAMIDE; MESNA; MITOMYCIN; VINBLASTINE;

ADULT; AGED; ALOPECIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DRUG FATALITY; DUODENUM ULCER; DYSPNEA; FEASIBILITY STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; LETHARGY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MALE; NAUSEA; POSTOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IFOSFAMIDE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MITOMYCIN; QUALITY OF LIFE; RADIOTHERAPY; TIME FACTORS; TREATMENT OUTCOME; VINDESINE;

EID: 23744483368     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2005.04.001     Document Type: Article

References (9)

1. W.J. Curran, and P.M. Stafford Lack of apparent difference in outcome between clinically staged IIIA and IIIB non-small cell lung cancer treated with radiation therapy J Clin Oncol 8 1990 409 415
2. P. Woll, and N. Thatcher Bronchus P. Price K. Sikora Treatment of cancer 1994 Chapman and Hill Medical London
3. G.M. Strauss, M.P. Langer, A.D. Elias, A.T. Skarin, and D.J. Sugarbaker Multimodality treatment of stage IIIA non-small cell lung carcinoma: a critical review of the literature and strategies for future research J Clin Oncol 10 1992 829 838
4. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 health survey: manual and interpretation guide. Boston, Massachusetts: Medical Outcomes Trust.
5. World Health Organization. WHO handbook for reporting results of cancer treatment. WHO offset publication no. 48. Geneva: WHO.
6. Department of Health Standing Medical Advisory Committee. The management of lung cancer: current clinical practices, 1994; report of a working group to the Standing Medical Advisory Committee. Department of Health. p. 27-8 [Appendix C].
7. F.A. Shepherd, M.R. Johnston, D. Payne, R. Burkes, J. Deslauriers, and Y. Cormier Randomized study of chemotherapy and surgery versus radiotherapy for stage IIIA non-small-cell lung cancer: a National Cancer Institute of Canada Clinical Trials Group study Br J Cancer 78 1998 683 685
8. F. Reboul, G. Chauvin, P. Vincent, Y. Brewer, C. Felix-Faure, and M. Taulelle Pre-operative radio-chemotherapy of stage III unresectable non-small cell lung cancer: results of a pilot study Bull Cancer 83 1996 300 306
9. K.M. Pisters, R.J. Ginsberg, D.J. Giroux, J.B. Putnam Jr., M.G. Kris, and D.H. Johnson Induction chemotherapy before surgery for early-stage lung cancer: a novel approach J Thorac Cardiovasc Surg 119 2000 429 439